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A B S T R A C T
Malaria continues to affect 500 million people worldwide every year. In this study, we compared the
protein proﬁle of uninfected and Plasmodium berghei-infected serum samples by one dimensional SDS-
PAGE analysis, MALDI-TOF/TOF mass spectrometry and conﬁrmed by semi-quantitative RT-PCR. Also the
protein interacting networks were established using STRING protein–protein interaction analysis. We
observed for the ﬁrst time the upregulation of FERM domain during P. berghei infection. We predict that
FRMD5 along with the other protein partners (identiﬁed by STRING analysis) are involved in the
merozoites entry or protein trafﬁcking where cell to cell interaction happens with the host erythrocyte;
hence, upregulation.
ã 2016 The Authors. Published by Elsevier B.V. on behalf of European Proteomics Association (EuPA). This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Malaria continues to affect 500 million people worldwide with
two-three million deaths per year and most of them are children
below ﬁve years in Sub-Sahara Africa [1]. Emerging drug resistance
in different species of Plasmodium, the parasite, has caused severe
obstacle for eradication and management of malaria [2]. This
situation is worse in underdeveloped and developing countries
where availability of medical facilities is far from desired standards
[3,4]. In recent years, proteomic studies have substantially
contributed in understanding the host (human)-pathogen (malaria
parasites) relationship [5], including infection-induced changes in
host erythrocyte membrane proteins [6]. Identiﬁed potential
disease related markers generally reﬂect rapid changes in
expression pattern in response to disease conditions and show
direct correlation with progression of disease [7]. In this direction,
proteomic proﬁle of serum can give insight into the systemic
reaction to a disease state and can serve as a pool of differentially
expressed proteins [8]. These proteins could potentially serve as an
early infection indicators for diagnosis or therapeutic targets.
Plasmodium falciparum is the major species involved in global
malaria. Cerebral malaria pathogenesis caused by P. falciparum is
poorly characterized and need to be better understood to identify* Corresponding author at: Undergraduate Programme, Indian Institute of
Science, Bangalore 560 012, India
E-mail address: vats@biochem.iisc.ernet.in (V. P.G.).
http://dx.doi.org/10.1016/j.euprot.2016.01.008
2212-9685/ã 2016 The Authors. Published by Elsevier B.V. on behalf of European Proteom
(http://creativecommons.org/licenses/by-nc-nd/4.0/).novel therapeutic targets. Certain components of cerebral malaria
have been investigated in the mouse model of malaria caused by
the infection with P. berghei. This infection in mice closely mimics P.
falciparum-induced cerebral malaria in humans [9]. The analysis of
the serum proteome can relate to a particular interested protein
that changes in expression or abundance in response to a disease
state. In this study, we have compared the serum protein proﬁle of
control and mice infected with P. berghei by one-dimensional (1D)
sodium dodecyl sulfate- polyacrylamide gel electrophoresis (1D-
SDS-PAGE) and identiﬁed the differentially expressed proteins by
matrix-assisted laser desorption/ionization time-of-ﬁght (MALDI-
TOF/TOF) mass spectrometry. By this approach, we obtained
differentially expressed protein proﬁle of the P. berghei-infected
and uninfected serum samples, which can identify potential
biomarkers related to malaria infection.
Swiss mice were obtained from Central Animal Facility, Indian
Institute of Science, Bangalore. All precautions were undertaken to
minimize suffering. Animal experiments in mice and all experi-
mental protocols were according to the Institutional Animal Care
and Use Committee guidelines. For parasite propagation, fresh
mice were injected intraperitoneally with P. berghei-infected
blood. Infected mice died between 5 and 6 days and were
conﬁrmed by Giemsa-stained smears. Control and P.berghei-
infected (day 5 post infection) blood were collected by cardiac
puncture, allowed to clot for 2 h at room temperature and
centrifuged at 5000 rpm for 15 min. The obtained serum was
stored at 80 C until further analysis. 150 mg of protein from
control and P. berghei-infected serum was separated on 10%ics Association (EuPA). This is an open access article under the CC BY-NC-ND license
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250 staining and differentially expressed band was identiﬁed by
MALDI-TOF/TOF mass spectrometry. The MALDI mass spectra were
obtained using an ULTRA FLEXtreme MALDI TOF/TOF (Bruker
Daltonics). Thus obtained peptide masses were searched against
SwissProt database employing Mascot (Matrix Science) database
for protein identiﬁcation. Protein matches with scores greater than
55 (p < 0.05) were considered signiﬁcant. The identiﬁed protein
was further analysed using STRING v9.1 (search tool for the
retrieval of interacting genes), which is an application that
aggregates available databases of known proteins. For the
validation of FRMD5 protein identiﬁed by MALDI-TOF/TOF-MS,
total RNA was isolated from control and P. berghei-infected blood
by TRI reagent (Sigma) and semi quantitative RT-PCR was carried
out with FRMD5-speciﬁc primers 50-ACGGCCGTCTTCTCTGTAAA-30
and 50-ATGTTGCTGGTGTTTGACCA-30, with a 204 bp PCR product
(96 C: 1 min; 60 C: 1 min; 72 C: 1 min; 30 cycles), visualized on
1.5% agarose gel with GAPDH as control. Statistical analysis of
arbitrary units derived from densitometric measurements of
protein bands from the study was carried out using SPSS software
(Version 13.0, SPSS, Chicago). All the data are presented as
mean  SEM (n = 3). Difference between groups was calculated by
Student’s t-test and p < 0.05 was considered signiﬁcant.
Comparative study of serum protein proﬁle of control and P.
berghei-infected mice was done by one dimensional sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). P.
berghei infection in mice was conﬁrmed by Giemsa staining of
blood smears (Fig. 1a). Equal amount of serum proteins was run on
a 10% SDS-PAGE gel, visualized by coomassie brilliant blue staining.
Fig. 1b represents protein proﬁle with differential expressions
across control and infected mice. A student’s t-test was performed
of a selected protein band (marked by an arrow, Fig. 1b) to
determine statistically signiﬁcant difference between control and
infected sample (Fig. 1c). Further, selected differentially expressedFig. 1. (a) Giemsa-stained blood thin smears of control mice (uninfected) and mice infe
proteins on a 10% gel. (c) Student’s t-test (n = 3, p < 0.05).protein band was analysed by MALDI-TOF/TOF mass spectrometry.
The obtained mass spectra were analysed by SwissProt database
search aided by Matrix Science for protein identiﬁcation. Protein
matches with scores greater than 55 (p < 0.05) were considered
signiﬁcant. The protein identiﬁed to be FERM domain containing
protein 5 (FRMD5). Next, functional association networks with the
FRMD5 were determined and predicted functional partners were
identiﬁed by STRING v9.1 (Fig. 2). To correlate and validate
differential expression pattern of FRMD5, total RNA was isolated
from control and P. berghei-infected mice and a semi-quantitative
RT-PCR was carried out with FRMD5 speciﬁc primers. A signiﬁcant
upregulation in FRMD5 expression seen in P. berghei-infected mice
compared to control (Fig. 3).
In this study, we demonstrate the differential expression of
protein in serum of P. berghei-infected mice. Earlier studies have
shown the importance of highly abundant serum proteins in
protection against various infections [10,11]. Therefore, we did not
adopt any additional processes to remove such proteins, as we
could risk losing important host serum proteins that, otherwise,
could have an important role in protection against infection.
In this study, we have identiﬁed the overexpressed FERM
domain present in the pooled sera of P. berghei-infected mice. This
could be due to a host response to combat this particular parasitic
infection. FERM domain is a known unique module involved in the
linkage of cytoplasmic proteins to the membrane [12]. They form a
family of proteins that mediate linkage of the cytoskeleton to the
plasma membrane [13]. This domain was originally identiﬁed in
band 4.1 (also known as protein 4.1) that was ﬁrst isolated from
human erythrocyte ghosts [14]. The presence of FERM domain in
the cell–cell contact protein talin [15] suggests that these proteins
link the membrane and the cytoskeleton in speciﬁc subcellular
environments. The functional role of the FERM domain in
maintaining cell integrity, motility and differentiation [11], and
its involvement in human diseases are known. Recently, there is acted with P. berghei. (b) SDS-PAGE of control (uninfected) and infected mice serum
Fig. 2. The protein–protein interaction networks of FRMD5 constructed by STRING.
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associated kinase 3(JAk 3) were fully protected against cerebral
malaria [16]. The intraerythrocytic parasites extensively remodel
their host cells.
Plasmodium parasites achieve massive changes in erythrocyte
structure by exporting proteins into the erythrocyte cytosol, some
of which interact with components of the host cytoskeleton and
plasma membrane [17]. Only a few of these exported proteins have
been studied in detail, one of it is the mature parasite-infected
erythrocyte surface antigen (MESA), which binds to the erythro-
cyte cytoskeleton associated protein Band 4.1, also known as 4.1RFig. 3. FRMD5 mRNA expression patterns [18] and another is Plasmodium helical interspersed subtelomeric
(PHIST) domain proteins, which play a role in modulating the
erythrocyte cytoskeleton [19]. Given the critical regulatory role
that the 4.1R FERM domain plays in uninfected erythrocytes, it is
not surprising that P. falciparum proteins also bind to it, and the
4.1R FERM domain is recognized by MESA [20] and PHIST [19].
Resultsofprotein–protein interaction analysisofFRMD5 revealed
several predicted protein partners. It is interesting to note that one of
the interacting proteins phospholamban (Pln) has been shown to
regulate the activity of the calcium pump, which is important for
growth of P. falciparum [21]. Similarly, myosin heavy polypeptide 6by semi-quantitative RT-PCR analysis.
62 V. P.G., K.M. P. / EuPA Open Proteomics 10 (2016) 59–62(Myh6) also an Frmd5 interacting protein shown to be involved in
gliding motility of P. berghei during host cell invasion [22]. These
indicate that FERM domain has several protein partners to provide a
link between cytoskeleton signals and membrane dynamics and
hence upregulation of this FERM domain protein in case of
Plasmodium-infected animal. Further studies identifying a mecha-
nistic role of FRMD5 in malaria infection could be valuable in
identifying the protein as possible diagnostic and pharmacological
target.
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